Código QR (código de barras bidimensional)

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review

Aim. To analyze the efficacy, safety and pharmacoeconomic indicators of ocrelizumab in adult patients with primary progressive multiple sclerosis (PPMS). Methods. An information search was conducted in the databases Embase, PubMed, Cochrane and eLibrary.ru. The levels of evidence were determined in...

ver descrição completa

Na minha lista:
Principais autores: D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, E. M. Olyushina, K. I. Polyakova, A. G. Fisun, M. G. Grinin, K. A. Kokushkin
Formato: Artigo
Idioma:Russo
Publicado em: Izdatelstvo OKI 2018-07-01
coleção:Качественная клиническая практика
Assuntos:
окрелизумаб
эффективность
безопасность
систематический обзор
первично-прогрессирующий рассеянный склероз
анти-в-клеточная терапия
моноклональные антитела
Acesso em linha:https://www.clinvest.ru/jour/article/view/405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados